Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Conference News ACC 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Yael L. Maxwell

April 07, 2024

News Daily News

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Todd Neale

June 20, 2023

News Conference News AHA 2022

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

Yael L. Maxwell

November 11, 2022

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Conference News EuroPCR 2019

ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety

L.A. McKeown

May 31, 2019

News Daily News

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Todd Neale

January 14, 2019

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

Presentation JIM 2018

Cangrelor is ready for prime time

Presenter: Dominick J. Angiolillo

February 23, 2018

Advertisement

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

Managing AF Patients Undergoing PCI—Some Lingering Questions

Observational Study Supports Continuing Oral Anticoagulation During PCI

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Cangrelor is ready for prime time

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content